DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization
Open Access
- 1 April 1999
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 18 (7) , 1815-1823
- https://doi.org/10.1093/emboj/18.7.1815
Abstract
Upon DNA damage, p53 has been shown to be modified at a number of N‐terminal phosphorylation sites including Ser15 and ‐33. Here we show that phosphorylation is induced as well at a novel site, Ser20. Phosphorylation at Ser15, ‐20 and ‐33 can occur within minutes of DNA damage. Interestingly, while the DNA‐binding activities of p53 appear to be dispensable, efficient phosphorylation at these three sites requires the tetramerization domain of p53. Substitution of an artificial tetramerization domain for this region also permits phosphorylation at the N‐terminus, suggesting that oligomerization is important for DNA damage‐induced signalling to p53.Keywords
This publication has 71 references indexed in Scilit:
- DNA damage activates p53 through a phosphorylation–acetylation cascadeGenes & Development, 1998
- DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 siteOncogene, 1998
- JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinasesOncogene, 1997
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- THE GENETIC DEFECT IN ATAXIA-TELANGIECTASIAAnnual Review of Immunology, 1997
- p53 in growth control and neoplasiaBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinasesNature, 1995
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992